Precigen (PGEN) Change in Account Payables (2012 - 2026)
Precigen's (PGEN) quarterly Change in Account Payables came in at -$9.5 million in Q1 2026, down 8030.77% year-on-year from $119950.5 in Q1 2025, and down 245.55% on a QoQ basis from $6.5 million in Q4 2025.
Precigen (PGEN) Change in Account Payables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Change in Account Payables data on file, last reported at -$9.5 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 8030.77% year-over-year to -$9.5 million in Q1 2026; TTM through Mar 2026 was -$628000.0, a 48.57% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 466.04% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$9.5 million, down from $6.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for PGEN reached as high as $6.5 million in Q4 2025 and fell as low as -$9.5 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$77375.0 across 5 years, with a median of -$97000.0 in 2022.
- Across the five-year window, Change in Account Payables plunged 24800.0% in 2023 and jumped 1165.46% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $457000.0 in 2022, then plunged by 244.86% to -$662000.0 in 2023, then slipped by 19.03% to -$788000.0 in 2024, then surged by 929.44% to $6.5 million in 2025, then slumped by 245.55% to -$9.5 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$9.5 million in Q1 2026, $6.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -9.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.51 Mn |
| Mar 31, 2026 | -9.51 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 801,000.00 |
| Jun 30, 2025 | 801,000.00 |
| Mar 31, 2025 | -117,000.00 |
| Mar 31, 2025 | -117,000.00 |
| Dec 31, 2024 | -788,000.00 |
| Dec 31, 2024 | -788,000.00 |
| Sep 30, 2024 | -841,000.00 |
| Sep 30, 2024 | -841,000.00 |
| Jun 30, 2024 | 525,000.00 |
| Jun 30, 2024 | 525,000.00 |
| Mar 31, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | -662,000.00 |
| Dec 31, 2023 | -662,000.00 |